An observational study in Normal Eyes and Ocular Pathology, sponsored by Optovue. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-03.
Sponsored by Optovue · Observational
Precision of OCT- and OCTA-based Ocular Measurements
The purpose of this study is to assess precision of measurements of vascular structures and the anatomical structures of the posterior pole of the eye based on OCTA and OCT scans in normal subjects, glaucoma patients, and retina patients, and to assess measurements of corneal layers based on corneal OCT scans in normal subjects and cornea patients.
Optovue is the lead sponsor of 16 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Seeing eye doctor for routine care
Exclusion Criteria:
no glaucoma or retinal pathology or corneal conditions
Device: SD-OCT
diagnosis of glaucoma
Device: SD-OCT
diagnosis of AMD, DR or other retinal pathology
Device: SD-OCT
wear contact lens or prior refractive surgery or having dry eye or KCN
Device: SD-OCT
Spectral Domain Optical Coherence Tomography for non-invasive, light-based, cross-sectional imaging of ocular structures
Repeatability and Reproducibility Standard Deviation of ocular measurements
calculated value minus the measured value
Time frame: Day 1
Repeatability and Reproducibility Coefficient of Variation of ocular measurements
maximum difference that is likely to occur between repeated measurements
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Optovue